GlassScriptPhysician profile
Haley S Gore
NPI 1861988156
$2,392.67
in general payments reported to CMS, 2019-2025
22 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $551 · 2023: $602 · 2024: $576 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.19 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $545.03 | 2021-2025 | Wegovy, Saxenda |
| Abbvie INC. | $459.47 | 2021-2025 | |
| Astellas Pharma US INC | $233.27 | 2021-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $155.08 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $148.11 | 2021-2024 | |
| Daiichi Sankyo INC. | $100.93 | 2021-2025 | Injectafer |
| Pfizer INC. | $99.80 | 2022-2025 | |
| Lilly USA, LLC | $89.52 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Exeltis, USA INC. | $87.20 | 2021-2025 | Slynd |
| Biogen, INC. | $71.55 | 2024 | Zurzuvae |
| Sumitomo Pharma America, INC. | $59.34 | 2023-2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $47.46 | 2023-2024 | Exparel |
| Mylan Pharmaceuticals INC. | $44.98 | 2021-2022 | |
| Millicent US INC | $40.05 | 2024 | |
| Shield Therapeutics INC | $38.97 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $38.42 | 2022 | |
| Agile Therapeutics, INC. | $29.43 | 2021-2022 | |
| Scynexis, INC. | $29.02 | 2022 | |
| Coopersurgical, INC. | $27.07 | 2024 | Paragard T 380a |
| Channel Medsystems, INC. | $20.51 | 2023 | |
| Merck Sharp & Dohme LLC | $15.60 | 2024 | Gardasil 9, Gardasil |
| Avion Pharmaceuticals | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Gore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.